Working… Menu
Trial record 1 of 1 for:    NCT03459469
Previous Study | Return to List | Next Study

Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03459469
Recruitment Status : Active, not recruiting
First Posted : March 9, 2018
Last Update Posted : March 19, 2021
Information provided by (Responsible Party):
Iterion Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 1, 2021
Estimated Study Completion Date : November 1, 2021